Four more Medicare Advantage prescription drug plans have received five-star ratings thanks to CMS’ recalculation.
CMS initially unveiled 2026 MA star ratings in October, with 18 MA-PD contracts scoring five stars overall.
On July 22, CMS released updated 2026 Medicare Advantage star ratings. The recalculation comes in the fallout of Clover Health’s lawsuit challenging the rating for its largest MA contract. The judge partially sided with Clover and called for a recalculation, and CMS voluntarily reevaluated other plans, as well. CMS appealed the Clover judgment one day prior to releasing the industry’s modified ratings. ARTICLE